Salahop, Marsifilena C.
HRN: 22-70-01 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/08/2023
CEFTAZIDIME 1GM (VIAL)
03/08/2023
03/14/2023
IV
1gm
Q8
CAP MR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes